A representative action was filed in the District Court of the Central District in Lod against the importer of medical marijuana Panaxia Pharmaceutical Industries.
The reason for the claim was the results of laboratory tests of the goods imported to her, which showed the level of active substances (cannabinoids) content to be significantly lower than declared and beyond the deviation permitted by law.
At the preliminary hearing, the company argued that the plaintiff relied on an incorrect system for testing the content of active substances, and that this is not an artificial drug, but a plant substance, the exact content of active substances in it is not controllable and depends on many different factors, such as plant variety, harvest season, etc.
The court considers the plaintiff’s claims to be sufficiently justified to accept the representative claim for consideration.